The four-year industrial PhD program will take place at Maastricht University in the Netherlands.
Gnosis by Lesaffre (Marcq-en-Baroeul, France), a supplier of vitamin K2 ingredients, is sponsoring a four-year academic program that will give one PhD student the chance to study vitamin K2 research and production. The program, called the Vitamin K2 Industrial PhD Program, will take place at Maastricht University in the Netherlands.
According to a Gnosis press release, this program goes beyond a traditional academic program by providing the student with more hands-on industrial experience with vitamin K2. “This program is different from the standard ‘academic’ PhD, which mostly focuses on academic skills and less on industrial skills. This latter is now recognized as an important asset for young scientists as it increases chances on the job market,” said Leon Schurgers, the professor at Maastricht University who will oversee the PhD student’s training, in a press release. Schurgers is a full professor of biochemistry of vascular calcification, vice chair of biochemistry at the Cardiovascular Research Institute Maastricht (CARIM), and chair of the Gnosis by Lesaffre Vitamin K2 Scientific Advisory Committee.
He added: “This program allows the candidate to explore research in a pragmatic and applicable way, working in proximity with those offering expertise in research as well as industry.”
The program has already chosen its student recipient: Rudolf Bittner. Bittner will study under the supervision of Schurgers as well as Olav Gåserød, PhD, a product development and research and development manager at Gnosis by Lesaffre, who will supervise Bittner on plant and production training.
“Industry-funded PhDs provide the student with an opportunity to pursue their research in a more vocational environment to develop relevant transferrable skills, allowing for a more seamless transition to the student’s first professional post-doctorate position,” said Gåserød.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.